# Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation

> **NCT02736227** · NA · COMPLETED · sponsor: **Northwestern University** · enrollment: 28 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Tacrolimus Withdrawal and Everolimus Monotherapy

## Key facts

- **NCT ID:** NCT02736227
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02736227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02736227, "Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02736227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*